% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Zhang:291690,
      author       = {Y. Zhang$^*$ and L. Liu$^*$ and P. Fan$^*$ and N. Bauer$^*$
                      and J. Gladkich$^*$ and E. Ryschich and A. V. Bazhin and N.
                      A. Giese and O. Strobel and T. Hackert and U. Hinz and M. W.
                      Gross$^*$ and F. Fortunato and I. Herr$^*$},
      title        = {{C}orrection: {A}spirin counteracts cancer stem cell
                      features, desmoplasia and gemcitabine resistance in
                      pancreatic cancer.},
      journal      = {OncoTarget},
      volume       = {15},
      number       = {1},
      issn         = {1949-2553},
      address      = {[Erscheinungsort nicht ermittelbar]},
      publisher    = {Impact Journals LLC},
      reportid     = {DKFZ-2024-01494},
      pages        = {504 - 506},
      year         = {2024},
      note         = {Original article: Oncotarget. 2015; 6:9999–10015.
                      https://doi.org/10.18632/oncotarget.3171},
      subtyp        = {Erratum/Correction},
      keywords     = {Humans / Gemcitabine / Deoxycytidine: analogs $\&$
                      derivatives / Deoxycytidine: pharmacology / Deoxycytidine:
                      therapeutic use / Pancreatic Neoplasms: drug therapy /
                      Pancreatic Neoplasms: pathology / Pancreatic Neoplasms:
                      metabolism / Drug Resistance, Neoplasm: drug effects /
                      Aspirin: pharmacology / Aspirin: therapeutic use /
                      Neoplastic Stem Cells: drug effects / Neoplastic Stem Cells:
                      pathology / Neoplastic Stem Cells: metabolism /
                      Antimetabolites, Antineoplastic: pharmacology / Gemcitabine
                      (NLM Chemicals) / Deoxycytidine (NLM Chemicals) / Aspirin
                      (NLM Chemicals) / Antimetabolites, Antineoplastic (NLM
                      Chemicals)},
      cin          = {G403},
      ddc          = {610},
      cid          = {I:(DE-He78)G403-20160331},
      pnm          = {319H - Addenda (POF4-319H)},
      pid          = {G:(DE-HGF)POF4-319H},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:39018218},
      doi          = {10.18632/oncotarget.28527},
      url          = {https://inrepo02.dkfz.de/record/291690},
}